近距離放射治療全球市場規模、佔有率、成長分析，按管理類型、按產品- 2023-2030年產業預測

Global Brachytherapy Market Size, Share, Growth Analysis, By Dosage Type(HDR and LDR), By Product(Prostate Cancer, Gynecological Cancer) - Industry Forecast 2023-2030

出版日期: 2024年02月02日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球近距離放射治療市場規模預計為5億美元，將從2023年的5.4億美元成長到2031年的9.9億美元，預測期間（2024-2031年）年複合成長率為7.95%。

全球近距離放射治療市場的預期成長受到多種因素的推動，例如癌症發病率上升、技術進步以及近距離放射治療採用率的顯著增加。近距離放射治療是放射治療的一種，使用透過導管插入體內的放射性物質來治療癌症。此方法使用人工產生的放射性核種，如銫137、銥192、金198、碘125和鈀103，已證明對治療局部腫瘤非常有效。根據國際癌症研究機構（IARC）估計，全球癌症病例數約為1,930萬例，預計到2030年將增加至2,460萬例。癌症發生率上升是市場的主要驅動力。放射線治療可單獨使用或與手術、免疫療法和化療合併使用，用於多種目的，包括預防性、安寧療護和根治性治療。其用途廣泛，加速了醫療專業人員的採用。放射治療技術的最新進展使得能夠精確地將高劑量輸送到目標區域，同時最大限度地減少對鄰近健康組織的傷害。這項進步顯著提高了局部腫瘤的控制和治癒率，推動了對放射線治療的需求。

自上而下和自下而上的方法已用於估計和檢驗全球近距離放射治療市場的規模，並估計其他各個相關子市場的規模。用於估計市場規模的調查方法包括以下細節：透過二次研究確定市場的主要企業，並透過初步和二次研究確定每個地區的市場佔有率。整個過程包括研究主要企業的年度和財務報告以及廣泛的採訪，以獲得執行長、副總裁、董事和行銷負責人等行業領導者的重要見解。所有佔有率比率和細節均使用二手資訊確定並使用主要資訊檢驗。本研究涵蓋的所有可能影響市場的參數都經過廣泛而詳細的考慮，透過初步研究檢驗並進行分析，以獲得最終的定量和定性資料。

全球近距離放射治療市場細分分析

全球近距離放射治療市場根據產品、給藥類型、應用和區域進行細分。依產品分類，市場分為種子、施用器和後荷機、電子近距離治療。依劑量類型，市場分為 HDR 和 LDR。依用途分為攝護腺癌、婦科癌、乳癌等。依地區分類，分為北美、歐洲、亞太地區、中東、非洲、拉丁美洲。

全球近距離放射治療市場的促進因素

微創治療方法因其術後併發症少、住院時間短、恢復快而受到患者青睞。由於近距離放射治療是一種微創治療方法，因此通常可以在門診進行治療。對微創治療的日益偏好是推動近距離放射治療市場擴張的關鍵因素。

近距離放射治療市場受到全球人口老化和預期壽命延長趨勢的推動。老年人的癌症發生率普遍較高，近距離放射治療已成為有效的治療選擇，特別是局部腫瘤。人口老化以及癌症篩檢和診斷技術的進步日益增加對近距離放射治療的需求。

全球近距離放射治療市場的限制因素

近距離放射治療需要專門的設備和基礎設施來進行治療計劃、放射治療和病人安全。初期成本（包括設備購置和安裝）可能會很高。如此大的初始投資可能是一個挑戰，特別是對於資源有限地區的衛生機構來說，這限制了近距離放射治療的普及。

全球近距離放射治療市場趨勢

人們對保留器官的治療的日益偏好推動近距離放射治療的廣泛普及，特別是在前列腺癌、乳腺癌和子宮頸癌等癌症中。近距離放射治療可提供精確的放射治療，最大限度地減少對附近健康組織的傷害，保護器官功能並提高患者的生活品質。向器官保存和微創治療的轉變擴大了近距離放射治療的使用。

執行摘要
調查方法
母市場分析
主要市場考察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- Start-Ups分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 主要投資分析
- 關鍵成功因素
- 競爭程度
市場動態及前景
- 市場動態
  - 促進因素
  - 機會
  - 抑制因素
  - 課題
- 監管形勢
- 波特的分析
- 對未來顛覆的特別見解
全球近距離放射治療市場：依管理類型
- 市場概況
- HDR 和 LDR
全球近距離放射治療市場：依產品
- 市場概況
- 攝護腺癌
- 婦科癌症
- 乳癌
- 其他
全球近距離放射治療市場規模：依地區
- 市場概況
- 北美洲
  - 美國
  - 加拿大
- 歐洲
  - 德國
  - 西班牙
  - 法國
  - 英國
  - 其他歐洲地區
- 亞太地區
  - 中國
  - 印度
  - 日本
  - 韓國
  - 其他亞太地區
- 拉丁美洲
  - 巴西
  - 其他拉丁美洲地區
- 中東、非洲
  - 海灣合作理事會國家
  - 南非
  - 其他中東、非洲地區
競爭形勢
- 前5名企業對比
- 主要企業市場定位（2021年）
- 主要市場參與者所採取的策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率（2021年）
主要企業簡介
- Eckert & Ziegler BEBIG（德國）
- Varian Medical Systems, Inc.（美國）
- Elekta AB（瑞典）
- IsoAid LLC（美國）
- Theragenics 公司（美國）
- CR Bard, Inc.（美國）
- Boston Scientific Corporation（美國）
- Isoray Inc.（美國）
- Nucletron B.V.（荷蘭）
- Huiheng Medical, Inc.（中國）
- iCAD, Inc.（美國）
- Elekta AB（瑞典）
- Nanobiotix SA（法國）
- BTG International Ltd.（英國）
- GE Healthcare（美國）
- IIBA Worldwide（比利時）
- Cianna Medical, Inc.（美國）
- Theragenics Corporation（美國）
- C4 Imaging LLC（美國）
- CIVCO Medical Solutions（美國）
- RaySearch Laboratories AB（瑞典）
- Hologic, Inc.（美國）

簡介目錄

Product Code: SQMIG35D2138

Global Brachytherapy Market size was valued at USD 0.50 Billion in 2022 and is poised to grow from USD 0.54 Billion in 2023 to USD 0.99 Billion by 2031, at a CAGR of 7.95% during the forecast period (2024-2031).

The anticipated growth of the global brachytherapy market is fuelled by several factors, including the escalating prevalence of cancer, technological advancements, and a notable uptick in brachytherapy adoption. Brachytherapy, a type of radiation therapy, involves the insertion of radioactive materials into the body through catheters to treat cancer. This method proves highly efficacious for treating localized tumours, employing artificially generated radionuclides like Caesium-137, Iridium-192, Gold-198, Iodine-125, and Palladium-103. According to estimates from the International Agency for Research on Cancer (IARC), global cancer incidence stands at approximately 19.3 million cases, projected to increase to 24.6 million by 2030. The expanding burden of cancer serves as a primary market driver. Radiation therapy serves various purposes, including prophylactic, palliative, or curative treatment, either alone or in conjunction with surgery, immunotherapy, or chemotherapy. The diverse array of applications has spurred heightened adoption by medical professionals. Recent strides in radiation therapy techniques allow for precise delivery of high doses to target areas while minimizing harm to adjacent healthy tissues. This advancement significantly enhances localized tumour control and cure rates, consequently driving demand for radiation therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Brachytherapy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Brachytherapy Market Segmental Analysis

Global Brachytherapy Market is segmented on the basis of product, dosage type, application and region. By product, the market is segmented into seeds, applicators & after loaders, electronic brachytherapy. By dosage type, market is segmented into HDR and LDR. By application, the market is segmented into prostate cancer, gynaecological cancer, breast cancer, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Brachytherapy Market

Patients favour minimally invasive treatment methods because they lead to fewer post-operative complications, shorter hospital stays, and quicker recovery periods. Brachytherapy, being a minimally invasive treatment option, is often feasible on an outpatient basis. The rising preference for minimally invasive procedures is a key factor driving the expansion of the brachytherapy market.

The brachytherapy market is propelled by the global trend of an aging population and longer life expectancy. With cancer incidence typically higher among older individuals, brachytherapy emerges as a viable treatment choice, particularly for localized tumours. The combination of an aging population and improvements in cancer screening and diagnosis fuels the demand for brachytherapy procedures.

Restraints in the Global Brachytherapy Market

Brachytherapy necessitates specialized equipment and infrastructure for treatment planning, radiation delivery, and ensuring patient safety. The initial expenses, encompassing the acquisition and installation of equipment, can be substantial. This considerable upfront investment may pose a challenge for healthcare facilities, particularly in regions with limited resources, thereby constraining the uptake of brachytherapy.

Market Trends of the Global Brachytherapy Market

The increasing inclination towards treatments that preserve organs is driving the popularity of brachytherapy, particularly in cancers like prostate, breast, and cervical cancer. Brachytherapy offers precise radiation delivery, minimizing harm to nearby healthy tissues, thus maintaining organ function and enhancing patients' quality of life. This shift towards organ preservation and minimally invasive therapies has resulted in greater utilization of brachytherapy.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
- Regulatory Landscape
- Porters Analysis
  - Competitive rivalry
  - Threat of Substitute Products
  - Bargaining Power of Buyers
  - Threat of New Entrants
  - Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
  - Political Impact
  - Economic Impact
  - Social Impact
  - Technical Impact
  - Environmental Impact
  - Legal Impact
Global Brachytherapy Market by Dosage Type
- Market Overview
- HDR and LDR
Global Brachytherapy Market by Product
- Market Overview
- Prostate Cancer
- Gynecological Cancer
- Breast Cancer
- Others
Global Brachytherapy Market Size by Region
- Market Overview
- North America
  - USA
  - Canada
- Europe
  - Germany
  - Spain
  - France
  - UK
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - South Korea
  - Rest of Asia-Pacific
- Latin America
  - Brazil
  - Rest of Latin America
- Middle East & Africa (MEA)
  - GCC Countries
  - South Africa
  - Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
  - By Development
  - By Company
  - By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Eckert & Ziegler BEBIG (Germany)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Varian Medical Systems, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Elekta AB (Sweden)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- IsoAid LLC (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Theragenics Corporation (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- C. R. Bard, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Boston Scientific Corporation (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Isoray Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Nucletron B.V. (Netherlands)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Huiheng Medical, Inc. (China)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- iCAD, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Elekta AB (Sweden)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Nanobiotix SA (France)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- BTG International Ltd. (United Kingdom)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- GE Healthcare (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- IBA Worldwide (Belgium)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Cianna Medical, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Theragenics Corporation (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- C4 Imaging LLC (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- CIVCO Medical Solutions (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- RaySearch Laboratories AB (Sweden)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Hologic, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments